384 related articles for article (PubMed ID: 20638491)
1. Vitamin D deficiency promotes growth of MCF-7 human breast cancer in a rodent model of osteosclerotic bone metastasis.
Ooi LL; Zheng Y; Zhou H; Trivedi T; Conigrave AD; Seibel MJ; Dunstan CR
Bone; 2010 Oct; 47(4):795-803. PubMed ID: 20638491
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D deficiency promotes prostate cancer growth in bone.
Zheng Y; Zhou H; Ooi LL; Snir AD; Dunstan CR; Seibel MJ
Prostate; 2011 Jun; 71(9):1012-21. PubMed ID: 21541977
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis.
Ooi LL; Zhou H; Kalak R; Zheng Y; Conigrave AD; Seibel MJ; Dunstan CR
Cancer Res; 2010 Mar; 70(5):1835-44. PubMed ID: 20160035
[TBL] [Abstract][Full Text] [Related]
4. 1,25(OH)
Lu G; Li J; Chu J; Jin S; Fu Z; Miao D; Yin Y
Biomed Pharmacother; 2017 Nov; 95():1033-1039. PubMed ID: 28922720
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of bone resorption and growth of breast cancer in the bone microenvironment.
Buijs JT; Que I; Löwik CW; Papapoulos SE; van der Pluijm G
Bone; 2009 Feb; 44(2):380-6. PubMed ID: 19041433
[TBL] [Abstract][Full Text] [Related]
6. Sagopilone inhibits breast cancer bone metastasis and bone destruction due to simultaneous inhibition of both tumor growth and bone resorption.
Strube A; Hoffmann J; Stepina E; Hauff P; Klar U; Käkönen SM
Clin Cancer Res; 2009 Jun; 15(11):3751-9. PubMed ID: 19470728
[TBL] [Abstract][Full Text] [Related]
7. Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer.
Yi B; Williams PJ; Niewolna M; Wang Y; Yoneda T
Cancer Res; 2002 Feb; 62(3):917-23. PubMed ID: 11830552
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis.
Zheng Y; Zhou H; Brennan K; Blair JM; Modzelewski JR; Seibel MJ; Dunstan CR
Bone; 2007 Feb; 40(2):471-8. PubMed ID: 17092788
[TBL] [Abstract][Full Text] [Related]
9. Osteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeutically.
Fisher JL; Thomas-Mudge RJ; Elliott J; Hards DK; Sims NA; Slavin J; Martin TJ; Gillespie MT
Cancer Res; 2006 Apr; 66(7):3620-8. PubMed ID: 16585187
[TBL] [Abstract][Full Text] [Related]
10. The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm.
Trivedi T; Zheng Y; Fournier PGJ; Murthy S; John S; Schillo S; Dunstan CR; Mohammad KS; Zhou H; Seibel MJ; Guise TA
Oncotarget; 2017 Apr; 8(16):26687-26701. PubMed ID: 28460457
[TBL] [Abstract][Full Text] [Related]
11. Effect of combination therapy with a novel bisphosphonate, minodronate (YM529), and docetaxel on a model of bone metastasis by human transitional cell carcinoma.
Inoue K; Karashima T; Fukata S; Nomura A; Kawada C; Kurabayashi A; Furihata M; Ohtsuki Y; Shuin T
Clin Cancer Res; 2005 Sep; 11(18):6669-77. PubMed ID: 16166446
[TBL] [Abstract][Full Text] [Related]
12. RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model.
Canon J; Bryant R; Roudier M; Branstetter DG; Dougall WC
Breast Cancer Res Treat; 2012 Oct; 135(3):771-80. PubMed ID: 22926264
[TBL] [Abstract][Full Text] [Related]
13. Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone.
Zheng Y; Zhou H; Modzelewski JR; Kalak R; Blair JM; Seibel MJ; Dunstan CR
Cancer Res; 2007 Oct; 67(19):9542-8. PubMed ID: 17909065
[TBL] [Abstract][Full Text] [Related]
14. Bone resorption increases tumour growth in a mouse model of osteosclerotic breast cancer metastasis.
Zheng Y; Zhou H; Fong-Yee C; Modzelewski JR; Seibel MJ; Dunstan CR
Clin Exp Metastasis; 2008; 25(5):559-67. PubMed ID: 18421566
[TBL] [Abstract][Full Text] [Related]
15. RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis.
Miller RE; Roudier M; Jones J; Armstrong A; Canon J; Dougall WC
Mol Cancer Ther; 2008 Jul; 7(7):2160-9. PubMed ID: 18606716
[TBL] [Abstract][Full Text] [Related]
16. The bone remodeling environment is a factor in breast cancer bone metastasis.
Ooi LL; Zheng Y; Stalgis-Bilinski K; Dunstan CR
Bone; 2011 Jan; 48(1):66-70. PubMed ID: 20472107
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.
Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T
Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090
[TBL] [Abstract][Full Text] [Related]
18. In vivo tibial compression decreases osteolysis and tumor formation in a human metastatic breast cancer model.
Lynch ME; Brooks D; Mohanan S; Lee MJ; Polamraju P; Dent K; Bonassar LJ; van der Meulen MC; Fischbach C
J Bone Miner Res; 2013 Nov; 28(11):2357-67. PubMed ID: 23649605
[TBL] [Abstract][Full Text] [Related]
19. Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer.
Swami S; Krishnan AV; Wang JY; Jensen K; Horst R; Albertelli MA; Feldman D
Endocrinology; 2012 Jun; 153(6):2576-87. PubMed ID: 22454149
[TBL] [Abstract][Full Text] [Related]
20. DHA is a more potent inhibitor of breast cancer metastasis to bone and related osteolysis than EPA.
Rahman MM; Veigas JM; Williams PJ; Fernandes G
Breast Cancer Res Treat; 2013 Oct; 141(3):341-52. PubMed ID: 24062211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
